POSTER SESSION V
Wednesday, March 24, 2010 — 9:30 AM - 12:00 Noon
Exhibit Hall
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
GYNECOLOGIC PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
117
Reversal of Progesterone Receptor Modulator Associated Endometrial Changes upon Completion of a Withdrawal Bleed
(1106)
OB Ioffe, RJ Zaino, GL Mutter - University of Maryland School of Medicine, Baltimore, MD; Hershey Medical Center, Hershey, PA; Brigham and Women's Hospital, Boston, MA
Endometrial Surveillance Outcomes for a Cohort of Breast Cancer Patients Treated with Tamoxifen
(1139)
MS McLemore, A Malpica - UT MD Anderson Cancer Center, Houston, TX
Resolving the Predictive Ability of Simple Hyperplasia
(1095)
O Habeeb, DB Seligson, CH Ersahin - Loyola University Medical Center, Maywood, IL; David Geffen School of Medicine at UCLA, Los Angeles, CA
Clinical Outcome in Diagnostically Ambiguous Foci of "Gland Crowding" in the Endometrium
(1105)
EC Huang, GL Mutter, CP Crum, MR Nucci - Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Internet-Based Assessment of Observer Variability for Diagnostically Challenging Endometrial Biopsies
(1137)
JD Marotti, K Glatz, V Parkash, JL Hecht - Beth Israel Deaconess Medical Center, Boston, MA; University of Basel, Basel, Switzerland; Bridgeport Hospital, Bridgeport, CT
Morphologic Criteria for Distinguishing Endometrial Adenocarcinoma from Complex Atypical Endometrial Hyperplasia
(1144)
K Mittal, S Sasturkar, A Salem - New York University School of Medicine, New York
Complex Atypical Hyperplasia: Improving the Prediction of Associated Carcinoma
(1128)
MM Leitao, Jr, G Han, NR Abu-Rustum, RR Barakat, RA Soslow - Memorial Sloan-Kettering Cancer Center, New York, NY
Papillary Endometrioid Carcinoma Is More Aggressive Than Endometrioid Adenocarcinoma FIGO Grade 2
(1081)
ED Euscher, A Malpica - MD Anderson Cancer Center, Houston, TX
Outcome and Survival in Women Diagnosed with Early Stage Endometrial Intraepithelial Carcinoma: The Role of Adjuvant Therapy
(1124)
JG Lake, KZ Hanley, MB Mosunjac - Emory University School of Medicine, Atlanta, GA; Emory University Hospital, Atlanta, GA
Endometrial Adenocarcinoma with Clear Cell Morphology: Interobserver Variability and Immunohistochemical Analysis Using Hepatocyte Nuclear Factor -1β
(1097)
G Han, D Delair, CB Gilks, M Kobel, PB Clement, AD Tabrizi, RA Soslow - Memorial Sloan-Kettering Cancer Center, New York; University of British Columbia, Vancouver, Canada; Tabriz University of Medical Science, Tabriz, Islamic Republic of Iran
New Antibodies for Clear Cell Carcinoma (Pax-8, HNF-α, vHL) Are Also Positive in Arias-Stella Reaction
(1038)
CE Aguilar, E Silva - Cedars-Sinai Medical Center, Los Angeles, CA
PTEN Immunohistochemistry in Endometrial Carcinomas: Correlation with Mutation Analysis
(1090)
K Garg, R Soslow, C Aghajanian, SU2C MSKCC Team, D Levine - Memorial Sloan Kettering Cancer Center, New York, NY
Significance of E-Cadherin and p16 Advanced Endometrial Cancer: A Gynecologic Oncology Group Phase II Study
(1180)
M Singh, KM Darcy, WE Brady, Z Weber, A Akalin, CW Whitney, R Zaino, N Ramirez, KK Leslie - SUNY at Stony Brook & SBUMC, Stony Brook, NY; Gynecologic Oncology Group, Buffalo, NY; University of Colorado Denver, Aurora, CO; University of Massachusetts, Worcester, MA; Christiana Gynecology Group, Newark, DE; Hershey Medical Center, Hershey, PA; Nationwide Children's Hospital, Columbus, OH; University of Iowa, Iowa City, IA
IMP2, a Promising Biomarker Identifies Precursor of Endometrioid Carcinoma
(1132)
Y Liu, L Zhang, K Dresser, D Lu - UMass Memorial Medical Center, University of Massachusetts, Worcester, MA
IMP2, an Adjunct Marker That Differentiates Endometrial Serous from Endometrioid Carcinomas
(1213)
L Zhang, Y Liu, D Lu - University of Massachusetts, Worcester, MA
Epithelial Membrane Protein-2 Expression Is an Early Predictor of Endometrial Cancer Development
(1094)
O Habeeb, L Goodglick, RA Soslow, R Rao, O Schirripa, S Horvath, J Braun, DB Seligson, M Wadehra - David Geffen School of Medicine at UCLA, Los Angeles, CA; Memorial Sloan-Kettering Cancer Center, New York, NY
Heparin-Binding EGF-Like Growth Factor Overexpression Is Associated with Aggressive Disease in Endometrial Carcinoma
(1196)
J Torres-Mora, CE Sheehan, JS Ross - Albany Medical College, Albany, NY
Vitamin D Receptor Expression in Normal Endometrium and Endometrial Carcinoma. A Tissue-Microarray Study
(1153)
J Pallares, S Lopez, M Santacana, X Dolcet, JM Valdivielso, J Valls, X Matias-Guiu - Hospital Universitari Armau de Vilanova-IRB, Lleida, Spain
Algorithmic Approach to Intraoperative Consultation/Frozen Section May Reduce Discrepancies and Surgical Understaging in Differrent Types of Endometrial Cancer
(1053)
A Cabrera, M Cibull, F Ueland, C DeSimone, RG Karabakhtsian - University of Kentucky, Lexington, KY
Frozen Section Diagnosis of Low Grade Endometrial Adenocarcinoma: Is It a Predictor of Lymph Node Status? A Multi-Institutional Study of 110 Cases
(1112)
S Karaburun, D Wagner, SM Lele, S Mandavilli - Harford Hospital, Hartford, CT; University of Nebraska Medical Center, Omaha, NB
Pathologic Ultrastaging of Sentinel Lymph Nodes in Endometrial Cancer
(1115)
F Khoury-Collado, RA Soslow, MP Murray, ML Gemignani, NR Abu Rustum - Memorial Sloan-Kettering Cancer Center, New York, NY
Incidence of Positive Pelvic Washings Obtained during Hysterectomy for Endometrial Adenocarcinoma: A Comparison of Robotic-Assisted Hysterectomy Versus Total Abdominal Hysterectomy
(1104)
S Hu, Y Sun, A Brown, S Mandavilli - Hartford Hospital, Hartford, CT
Artefactual Changes in Robot-Assisted and Laparoscopic Hysterectomies
(1121)
A Krizova, BA Clarke, M Bernardini, S James, S Boerner, AM Mulligan - University of Toronto, Toronto, Canada; University Health Network, Toronto, Canada; UHN, Toronto, Canada; St. Micheal's Hospital, Toronto, Canada
Robotic Assisted Hysterectomies Increase Tubal Contaminants
(1072)
DF DeLair, RA Soslow, MM Leitao, Jr - Memorial Sloan-Kettering Cancer Center, New York, NY
Histologic Effects of Short Term Progestin Therapy on Endometrioid Adenocarcinoma
(1211)
RJ Zaino, WE Brady, W Todd, K Leslie, E Fischer, H Ball - Hershey Med Ctr, Hershey, PA; GOG, Buffalo, NY; U Iowa Med Ctr, Iowa City, IA; UNM, Albuquerque, NM; U Mass Med Ctr, Worcester, MA
Uterine Involvement by Colorectal Adenocarcinoma: Morphologic and Immunohistochemical Patterns That May Mimic Primary Endometrial, Endocervical or Vaginal Adenocarcinoma
(1147)
A Naujokas, JT Rabban - UCSF, San Francisco, CA
Synchronous and Metachronous Breast and Endometrial Cancer
(1138)
RC Marques, F Silva, S Andre, A Felix - IPO Lisboa Francisco Gentil, Lisboa, Portugal
Individual Tumor Cell Apoptoses in Uterine Smooth Muscle Tumors
(1107)
PPC Ip, KY Tse, ANY Cheung - University of Hong Kong, Queen Mary Hospital, Hong Kong, SAR, Hong Kong
Tissue Array Analysis of Apoptotic and Cell Cycle Regulatory Markers in Benign and Malignant Uterine Smooth Muscle Tumours: A Clinicopathologic Study of 52 Cases
(1200)
P Vasudev, M Farag, C Salib, D Browning, W Foster, O Boutross-Tadross - McMaster University, Hamilton, Canada
Small (≤ 5 cm) Uterine Leiomyosarcomas Are Rare, Frequently Misdiagnosed and as Clinically Aggressive as Larger Tumors
(1187)
R Soslow, M Leitao, O Zivanovic, L Jacks, M Hensley, E Veras - Memorial Sloan-Kettering Cancer Center, New York, NY
Immunohistochemical Expression of Estrogen and Progesterone Receptors and Outcomes in Patients with Newly Diagnosed Uterine Leiomyosarcoma
(1129)
MM Leitao, Jr, ML Hensley, R O'Cearbhaill, RA Soslow - Memorial Sloan-Kettering Cancer Center, New York, NY
FISH for Diagnosis of Endometrial Stromal Sarcoma
(1042)
R Ali, CH Lee, A Zayed, A Dastranj, A Elomami, E Mehl, J Senz, CB Gilks, D Huntsman - Vancouver General Hospital, BC Cancer Agency, and Genetic Pathology Evaluation Centre, Vancouver, BC, Canada; Tabriz University of Medical Science, Tabriz, Islamic Republic of Iran
The Presence of Heterologous Elements Increases the Risk of Recurrence in Mullerian Adenosarcomas
(1076)
V Dube, S Nofech-Mozes, N Ismiil, RS Saad, Z Ghorab, MA Khalifa - Sunnybrook Health Sciences Centre, Toronto, Canada
Immunohistochemical Characterization of Mullerian Adenosarcomas
(1143)
L Mirham, MA Khalifa, S Nofech-Mozes, N Ismiil, RS Saad, Z Ghorab, V Dube - Sunnybrook Health Sciences Centre, Toronto, Canada
button next to any title to add to Itinerary Planner...
Add
